Work

Highly purified mutant E112K of cholera toxin elicits protective lung mucosal immunity to diphtheria toxin

Year: 2001

Type: article

Source: Vaccine

DOI: 10.1016/s0264-410x(01)00412-1

Authors: Mari Ohmura, Masafumi Yamamoto, Hiroshi Kiyono, Kohtaro Fujihashi, Yoshifumi Takeda, Jerry R McGhee

Institutions: University of Alabama at Birmingham, UAB Medicine, Niigata University, Nihon University, Research Institute for Microbial Diseases, The University of Osaka, The University of Osaka, Jissen Women's University

Language: English

Topic: Diphtheria, Corynebacterium, and Tetanus

Subfield: Endocrinology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Institute on Deafness and Other Communication Disorders, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Dental and Craniofacial Research

Awards: Alternative approaches for NALT-based immunity to respiratory pathogens, G1205486287, G1532581934, G1537911641, SALIVARY IGA RESPONSES--REGULATION BY T CELLS, G2403397956, CELLULAR AND MOLECULAR MECHANISMS FOR MUCOSAL IMMUNITY, G3166358348, ENTERIC PATHOGENS - MUCOSAL RESEARCH UNIT, G3365971747, G4451597083, CYSTIC FIBROSIS GENE THERAPY CORE CENTER, MOLECULAR EVASION OF ORAL TOLERANCE FOR MCCOSAL VACCINES, Ab5 Toxins Nasal Adjuvant Target the Olfactory Bulbs/CNS

OpenAlex ID: W2004992220

FWCI: 1.384

Cites: 27

Cited by: 17

Related to: 10